| Year |
Citation |
Score |
| 2020 |
Cook IA, Hunter AM, Caudill MM, Abrams MJ, Leuchter AF. Prospective testing of a neurophysiologic biomarker for treatment decisions in major depressive disorder: The PRISE-MD trial. Journal of Psychiatric Research. 124: 159-165. PMID 32169689 DOI: 10.1016/J.Jpsychires.2020.02.028 |
0.485 |
|
| 2019 |
Cook IA, Congdon E, Krantz DE, Hunter AM, Coppola G, Hamilton SP, Leuchter AF. Time Course of Changes in Peripheral Blood Gene Expression During Medication Treatment for Major Depressive Disorder. Frontiers in Genetics. 10: 870. PMID 31620172 DOI: 10.3389/Fgene.2019.00870 |
0.359 |
|
| 2019 |
Corlier J, Wilson A, Hunter AM, Vince-Cruz N, Krantz D, Levitt J, Minzenberg MJ, Ginder N, Cook IA, Leuchter AF. Changes in Functional Connectivity Predict Outcome of Repetitive Transcranial Magnetic Stimulation Treatment of Major Depressive Disorder. Cerebral Cortex (New York, N.Y. : 1991). PMID 30953441 DOI: 10.1016/J.Brs.2018.12.812 |
0.477 |
|
| 2019 |
Hunter AM, Minzenberg MJ, Cook IA, Krantz DE, Levitt JG, Rotstein NM, Chawla SA, Leuchter AF. Concomitant medication use and clinical outcome of repetitive Transcranial Magnetic Stimulation (rTMS) treatment of Major Depressive Disorder. Brain and Behavior. e01275. PMID 30941915 DOI: 10.1002/Brb3.1275 |
0.444 |
|
| 2017 |
Hunter AM, Nghiem TX, Cook IA, Krantz DE, Minzenberg MJ, Leuchter AF. Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder. Clinical Eeg and Neuroscience. 1550059417746212. PMID 29224411 DOI: 10.1177/1550059417746212 |
0.486 |
|
| 2017 |
Leuchter MK, Donzis EJ, Cepeda C, Hunter AM, Estrada-Sánchez AM, Cook IA, Levine MS, Leuchter AF. Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development? Frontiers in Neurology. 8: 91. PMID 28424652 DOI: 10.3389/Fneur.2017.00091 |
0.34 |
|
| 2017 |
Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF. Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder? International Review of Psychiatry (Abingdon, England). 1-17. PMID 28362541 DOI: 10.1080/09540261.2017.1297697 |
0.447 |
|
| 2017 |
Leuchter A, Espinoza R, Suthana N, Hunter A, Cook I. Synergistic effects of ketamine and theta burst stimulation in the treatment of major depressive disorder (MDD) Brain Stimulation. 10: 492. DOI: 10.1016/J.Brs.2017.01.438 |
0.432 |
|
| 2016 |
Leuchter AF, Hunter AM, Jain FA, Tartter M, Crump C, Cook IA. Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder. Journal of Psychiatric Research. 84: 174-183. PMID 27770740 DOI: 10.1016/J.Jpsychires.2016.10.002 |
0.414 |
|
| 2016 |
Scanlon GC, Jain FA, Hunter AM, Cook IA, Leuchter AF. Neurophysiologic Correlates of Headache Pain in Subjects With Major Depressive Disorder. Clinical Eeg and Neuroscience. PMID 27000108 DOI: 10.1177/1550059416632411 |
0.337 |
|
| 2016 |
Hunter AM, Leuchter AF. Changes in resting-state quantitative electroencephalography (qEEG) and symptom severity during repetitive transcranial magnetic stimulation (rTMS) treatment in major depressive disorder (MDD): Case-studies Brain Stimulation. 9: e4-e5. DOI: 10.1016/J.Brs.2016.06.017 |
0.412 |
|
| 2015 |
Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF. Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder. Psychopharmacology. PMID 26319158 DOI: 10.1007/S00213-015-4047-2 |
0.453 |
|
| 2015 |
Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, ... ... Hunter AM, et al. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimulation. 8: 787-94. PMID 26143022 DOI: 10.1016/J.Brs.2015.05.005 |
0.364 |
|
| 2015 |
Jain FA, Hunter AM, Leuchter AF, Brooks JO. A role for profiles of patient-specific depression characteristics and socioeconomic factors in the prediction of antidepressant treatment outcome. The Journal of Clinical Psychiatry. 76: 327. PMID 25830451 DOI: 10.4088/Jcp.14Lr09483 |
0.421 |
|
| 2015 |
Leuchter AF, Hunter AM, Krantz DE, Cook IA. Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments. Annals of the New York Academy of Sciences. 1344: 78-91. PMID 25809789 DOI: 10.1111/Nyas.12742 |
0.426 |
|
| 2015 |
Caudill MM, Hunter AM, Cook IA, Leuchter AF. The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder. Clinical Eeg and Neuroscience. 46: 277-84. PMID 25258429 DOI: 10.1177/1550059414532443 |
0.486 |
|
| 2014 |
Leuchter AF, Hunter AM, Krantz DE, Cook IA. Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder. Dialogues in Clinical Neuroscience. 16: 525-37. PMID 25733956 |
0.366 |
|
| 2014 |
Leuchter AF, Hunter AM, Tartter M, Cook IA. Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. The British Journal of Psychiatry : the Journal of Mental Science. 205: 443-9. PMID 25213159 DOI: 10.1192/Bjp.Bp.113.140343 |
0.482 |
|
| 2014 |
Jain FA, Cook IA, Leuchter AF, Hunter AM, Davydov DM, Ottaviani C, Tartter M, Crump C, Shapiro D. Heart rate variability and treatment outcome in major depression: a pilot study. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. 93: 204-10. PMID 24769434 DOI: 10.1016/J.Ijpsycho.2014.04.006 |
0.467 |
|
| 2014 |
Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM, Cook IA. Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project. Journal of Psychiatric Research. 54: 11-8. PMID 24726639 DOI: 10.1016/J.Jpsychires.2014.03.009 |
0.396 |
|
| 2014 |
Cook IA, Hunter AM, Korb AS, Leuchter AF. Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder? Journal of Psychiatric Research. 53: 69-75. PMID 24630467 DOI: 10.1016/J.Jpsychires.2014.01.018 |
0.42 |
|
| 2013 |
Hunter AM, Cook IA, Abrams M, Leuchter AF. Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes? Medical Hypotheses. 81: 1004-11. PMID 24112999 DOI: 10.1016/J.Mehy.2013.09.016 |
0.475 |
|
| 2013 |
Hunter AM, Leuchter AF, Power RA, Muthén B, McGrath PJ, Lewis CM, Cook IA, Garriock HA, McGuffin P, Uher R, Hamilton SP. A genome-wide association study of a sustained pattern of antidepressant response. Journal of Psychiatric Research. 47: 1157-65. PMID 23726668 DOI: 10.1016/J.Jpsychires.2013.05.002 |
0.338 |
|
| 2013 |
Hunter AM, Korb AS, Cook IA, Leuchter AF. Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication? The Journal of Neuropsychiatry and Clinical Neurosciences. 25: 126-33. PMID 23686030 DOI: 10.1176/Appi.Neuropsych.11110330 |
0.421 |
|
| 2013 |
Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. The Journal of Clinical Psychiatry. 74: 51-6. PMID 23419226 DOI: 10.4088/Jcp.10M06813 |
0.478 |
|
| 2013 |
Jain FA, Hunter AM, Brooks JO, Leuchter AF. Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depression and Anxiety. 30: 624-30. PMID 23288666 DOI: 10.1002/Da.22045 |
0.412 |
|
| 2012 |
Leuchter A, Cook IA, Hunter AM. Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'. Journal of Psychopharmacology (Oxford, England). 26: 1162-3; author reply. PMID 22807041 DOI: 10.1177/0269881111430732 |
0.362 |
|
| 2012 |
Hunter AM, Cook IA, Leuchter AF. Does prior antidepressant treatment of major depression impact brain function during current treatment? European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 711-20. PMID 22445212 DOI: 10.1016/J.Euroneuro.2012.02.005 |
0.493 |
|
| 2012 |
Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S. Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression. Plos One. 7: e32508. PMID 22384265 DOI: 10.1371/Journal.Pone.0032508 |
0.373 |
|
| 2011 |
Hunter AM, Cook IA, Greenwald SD, Tran ML, Miyamoto KN, Leuchter AF. The antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. 28: 478-82. PMID 21946361 DOI: 10.1097/Wnp.0B013E318230Da8A |
0.473 |
|
| 2011 |
Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex activity and early symptom improvement during treatment for major depressive disorder. Psychiatry Research. 192: 188-94. PMID 21546222 DOI: 10.1016/J.Pscychresns.2010.12.007 |
0.494 |
|
| 2011 |
Muthén B, Asparouhov T, Hunter AM, Leuchter AF. Growth modeling with nonignorable dropout: alternative analyses of the STAR*D antidepressant trial. Psychological Methods. 16: 17-33. PMID 21381817 DOI: 10.1037/A0022634 |
0.326 |
|
| 2010 |
Hunter AM, Cook IA, Leuchter AF. Impact of antidepressant treatment history on clinical outcomes in placebo and medication treatment of major depression. Journal of Clinical Psychopharmacology. 30: 748-51. PMID 21057245 DOI: 10.1097/Jcp.0B013E3181Faa474 |
0.469 |
|
| 2010 |
Hunter A, Bordelon Y, Cook I, Leuchter A. QEEG Measures in Huntington's Disease: A Pilot Study. Plos Currents. 2: RRN1192. PMID 21037796 DOI: 10.1371/Currents.Rrn1192 |
0.316 |
|
| 2010 |
Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, Faull K, Whitelegge J, Andrews AM, Loo J, Way B, Nelson SF, Horvath S, Lebowitz BD. Biomarkers to predict antidepressant response. Current Psychiatry Reports. 12: 553-62. PMID 20963521 DOI: 10.1007/S11920-010-0160-4 |
0.429 |
|
| 2010 |
Hunter AM, Leuchter AF, Cook IA, Abrams M. Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment. Acta Psychiatrica Scandinavica. 122: 461-9. PMID 20384600 DOI: 10.1111/J.1600-0447.2010.01560.X |
0.377 |
|
| 2010 |
Farahbod H, Cook IA, Korb AS, Hunter AM, Leuchter AF. Amygdala lateralization at rest and during viewing of neutral faces in major depressive disorder using low-resolution brain electromagnetic tomography. Clinical Eeg and Neuroscience. 41: 19-23. PMID 20307012 DOI: 10.1177/155005941004100106 |
0.341 |
|
| 2010 |
Hunter AM, Muthén BO, Cook IA, Leuchter AF. Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder. Journal of Psychiatric Research. 44: 90-8. PMID 19631948 DOI: 10.1016/J.Jpsychires.2009.06.006 |
0.466 |
|
| 2009 |
Leuchter AF, Cook IA, Hunter AM, Korb AS. A new paradigm for the prediction of antidepressant treatment response. Dialogues in Clinical Neuroscience. 11: 435-46. PMID 20135901 |
0.36 |
|
| 2009 |
Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Research. 174: 152-7. PMID 19853417 DOI: 10.1016/J.Pscychresns.2009.04.011 |
0.504 |
|
| 2009 |
Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE. Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. Journal of Clinical Psychopharmacology. 29: 372-7. PMID 19593178 DOI: 10.1097/Jcp.0B013E3181Ac4Aaf |
0.361 |
|
| 2009 |
Korb AS, Hunter AM, Cook IA, Leuchter AF. Rostral anterior cingulate cortex theta current density and response to antidepressants and placebo in major depression. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 120: 1313-9. PMID 19539524 DOI: 10.1016/J.Clinph.2009.05.008 |
0.384 |
|
| 2009 |
Leuchter AF, Cook IA, Hunter A, Korb A. Use of clinical neurophysiology for the selection of medication in the treatment of major depressive disorder: the state of the evidence. Clinical Eeg and Neuroscience. 40: 78-83. PMID 19534301 DOI: 10.1177/155005940904000207 |
0.407 |
|
| 2009 |
Hunter AM, Leuchter AF, Cook IA, Abrams M, Siegman BE, Furst DE, Chappell AS. Brain functional changes and duloxetine treatment response in fibromyalgia: a pilot study. Pain Medicine (Malden, Mass.). 10: 730-8. PMID 19453962 DOI: 10.1111/J.1526-4637.2009.00614.X |
0.471 |
|
| 2009 |
Hunter AM, Ravikumar S, Cook IA, Leuchter AF. Brain functional changes during placebo lead-in and changes in specific symptoms during pharmacotherapy for major depression. Acta Psychiatrica Scandinavica. 119: 266-73. PMID 19077131 DOI: 10.1111/J.1600-0447.2008.01305.X |
0.421 |
|
| 2008 |
Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B. Changes in brain function during administration of venlafaxine or placebo to normal subjects. Clinical Eeg and Neuroscience. 39: 175-81. PMID 19044214 DOI: 10.1177/155005940803900405 |
0.393 |
|
| 2008 |
Korb AS, Cook IA, Hunter AM, Leuchter AF. Brain electrical source differences between depressed subjects and healthy controls. Brain Topography. 21: 138-46. PMID 18958615 DOI: 10.1007/S10548-008-0070-5 |
0.371 |
|
| 2007 |
Hunter AM, Cook IA, Leuchter AF. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. The Psychiatric Clinics of North America. 30: 105-24. PMID 17362807 DOI: 10.1016/J.Psc.2006.12.002 |
0.496 |
|
| 2006 |
Hunter AM, Leuchter AF, Morgan ML, Cook IA. Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression. The American Journal of Psychiatry. 163: 1426-32. PMID 16877657 DOI: 10.1176/Ajp.2006.163.8.1426 |
0.479 |
|
| 2005 |
Hunter AM, Leuchter AF, Morgan ML, Cook IA, Abrams M, Siegman B, DeBrota DJ, Potter WZ. Neurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 792-9. PMID 15637637 DOI: 10.1038/Sj.Npp.1300652 |
0.411 |
|
| 2003 |
Hunter AM, Balleine BW, Minor TR. Helplessness and escape performance: glutamate-adenosine interactions in the frontal cortex. Behavioral Neuroscience. 117: 123-35. PMID 12619915 DOI: 10.1037//0735-7044.117.1.123 |
0.511 |
|
| 2002 |
Minor TR, Hunter AM. Stressor controllability and learned helplessness research in the United States: sensitization and fatigue processes. Integrative Physiological and Behavioral Science : the Official Journal of the Pavlovian Society. 37: 44-58. PMID 12069365 DOI: 10.1007/Bf02688805 |
0.499 |
|
| Show low-probability matches. |